Minerva Neurosciences NERV
NASDAQ NERV
$4.43 -0.26 (-5.54%)
At close: Sep 4, 2026 · 4:00 PM EDT

Minerva Neurosciences (NERV) Acquisitions (2014)

Minerva Neurosciences' (NERV) quarterly Acquisitions came in at $1.2 million in Q1 2014.

Analysis

Minerva Neurosciences (NERV) Acquisitions (2014) Analysis & Trends

Minerva Neurosciences (NERV) has 1 years of Acquisitions data on file, last reported at $1.2 million in Q1 2014.

  • Quarterly Acquisitions changed N/A year-over-year to $1.2 million in Q1 2014, while the trailing twelve-month figure through Dec 2014 was $1.2 million (changed N/A YoY) and the FY2014 annual result came in at $1.2 million, up 84.94% from the prior year.
  • Acquisitions held at $1.2 million in Q1 2014.
  • In the past five years, Acquisitions ranged from a high of $1.2 million in Q1 2014 to a low of $1.2 million in Q1 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Minerva Neurosciences 207.37 Mn 207.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 1.17 Mn